Update shared on 25 Nov 2025
Fair value Decreased 6.91%Narrative Update on Alkyl Amines Chemicals
Analysts have adjusted their price target for Alkyl Amines Chemicals downward from ₹2,423.50 to ₹2,256.00, citing more conservative expectations for the company's future revenue growth and profit margins.
What's in the News
- A Special or Extraordinary Shareholders Meeting is scheduled for December 20, 2025 and will be conducted via postal ballot in India (Key Developments)
- A Board Meeting is set for November 4, 2025 at 11:45 Indian Standard Time. The agenda includes approval of unaudited financial results for the quarter and half year ended September 30, 2025, as well as consideration of a revision in remuneration (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has fallen from ₹2,423.50 to ₹2,256.00, marking a moderate downward revision.
- Discount Rate has declined slightly from 13.44% to 13.34%.
- Revenue Growth forecast has decreased significantly, moving from 20.62% to 14.40%.
- Net Profit Margin estimate is lower, shifting from 14.93% to 13.82%.
- Future P/E ratio has risen from 43.65x to 51.31x. This indicates higher valuation expectations relative to earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.